Dissolvable 3D-Printed Patch Aims to Improve Skin Cancer Treatment

• The 3D-printed patch utilizes microscopic needles that dissolve upon application, engineered to reduce patient discomfort and eliminate medical sharps waste.
• Formulated through a single-step manufacturing method, the system simultaneously loads and delivers two active anti-cancer compounds: curcumin and 5-fluorouracil.
• Described in Advanced Healthcare Materials, the research aims to streamline treatment regimens for localized skin cancer variants.

Pathogenesis of Localized Skin Cancer and Current Treatment Hurdles

Managing localized skin lesions often involves surgical excision, topical chemotherapy creams, or intralesional injections. Standard therapies can present significant compliance challenges due to local skin irritation, scarring, and procedure-related anxiety. According to Prof. Dimitrios A. Lamprou, chair of biofabrication and advanced manufacturing at the school of pharmacy at Queen’s University Belfast, conventional modalities frequently require repeated applications or invasive steps that generate unwanted side effects and patient apprehension.

Mechanisms of the Dissolvable Microneedle Delivery System

The newly engineered patch relies on an advanced manufacturing method that blends anti-cancer agents directly into a printable resin matrix prior to the fabrication of the microneedles. Rutuja N. Meshram, a final-year PhD student and co-author of the study, noted that this technique allows for high drug loading and a controlled, two-stage release profile directly at the tumor site.

By penetrating the stratum corneum without stimulating nerve endings that register deep pain, the microneedles dissolve entirely within the dermal tissue. This approach minimizes the risk of accidental needle-stick injuries for healthcare personnel and reduces overall medical sharps waste. Furthermore, the foundational study, published in Advanced Healthcare Materials, indicates that this manufacturing framework could eventually be adapted for broader pharmaceutical applications, including vaccine distribution and the administration of other macromolecular therapeutics.

Regulatory and Manufacturing Considerations in Advanced Biofabrication

The study was supported by the Joint Commissioner, Education Branch, Social Welfare in Maharashtra, India. The integration of 3D-printing technologies into oncology care points toward a future of patient-tailored interventions designed to reduce morbidity and enhance adherence across diverse patient populations.

*Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.*